Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as a differentiating factor
- PMID: 20552178
- PMCID: PMC2921491
- DOI: 10.1007/s00228-010-0854-x
Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as a differentiating factor
Comment on
-
In vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A.Eur J Clin Pharmacol. 2010 Mar;66(3):275-83. doi: 10.1007/s00228-009-0760-2. Epub 2009 Dec 11. Eur J Clin Pharmacol. 2010. PMID: 20012430
References
-
- Olubodun JO, Ochs HR, von Moltke LL, Roubenoff R, Hesse LM, Harmatz JS, Shader RI, Greenblatt DJ. Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men. Br J Clin Pharmacol. 2003;56:297–304. doi: 10.1046/j.0306-5251.2003.01852.x. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
